MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Comprehensive loss-$3,528K Gain from insurancerecovery$1,317K Interest income$128K (-38.46%↓ Y/Y)Net loss-$3,528K (-15.41%↓ Y/Y)Total other income,net$1,445K (153.06%↑ Y/Y)License Agreement$1,000K (-42.86%↓ Y/Y)Purchase Agreement$800K Option Agreement$274K Loss from operations-$4,973K (-37.07%↓ Y/Y)Total revenues$2,074K (3.70%↑ Y/Y)Total cost andexpenses$7,047K (25.21%↑ Y/Y)General andadministrative$6,088K (13.96%↑ Y/Y)Research and development$959K (235.31%↑ Y/Y)
Income Statement
source: myfinsight.com

Cyclerion Therapeutics, Inc. (CYCN)

Cyclerion Therapeutics, Inc. (CYCN)